RSS

Sanofi Pasteur

Global healthcare company Sanofi has announced it is investing €170 million to expand its vaccine manufacturing site in Val de Reuil, France. more

News

After being informed by BARDA that funding of Zika-related projects will be reduced, Sanofi has announced in a statement that it will ‘not continue the development of, or seek a licence for the Zika vaccine candidate at this time’. more

News

Sanofi has announced the completion of its acquisition of a privately-held US vaccines biotech company, Protein Sciences, following Federal Trade Commission approval. more

News

Sanofi and Sanofi Pasteur have announced an agreement with MedImmune to develop and commercialise a monoclonal antibody for the prevention of Respiratory Syncytial Virus (RSV). more

News

sanofi.jpg

360b / Shutterstock.com

In two separate press statements, Sanofi announced it has concluded its business swap with Boehringer Ingelheim, and has also closed its European vaccines joint venture with MSD (Merck & Co.). more

News

This month will mark the last time that one type of polio will ever be transmitted to a child. 2016 might also be the year that marks the overall end of the polio era, says Sanofi more

News

A US district court jury have ruled that the asserted claims of two Amgen patents for antibodies targeting PCSK9 are valid, yet Sanofi and Regeneron Pharmaceuticals have announced that they disagree with the verdict more

News

Sanofi Pasteur and MSD, known as Merck in the US, announced their intent to end their joint vaccines operations in Europe more

News

With Valentines Day over and Easter fast-approaching, the second month of the year is already drawing to a close. We take a look at our most read stories from the last month. Two down and ten more to go… more

Opinion

Sanofi Pasteur, the vaccines division of Sanofi, has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease more

News

Sanofi is to partially fund the Human Vaccines Project, a non-profit partnership aiming to solve the primary problems impeding vaccine/immunotherapy development more

News

Mexican authorities have granted marketing authorisation to Sanofi Pasteur’s Dengvaxia, making it the first vaccine to be licensed for the prevention of dengue more

News

The first shipment of ShanIPV(TM), an injectable, inactivated polio vaccine (IPV) will occur this week more

News